Heartflow, Inc.(HTFL)
Clinical Decision Support
Clinical Decision Support
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-17 | Rogers Campbell Chief Medical Officer | Sale | -9,219 | -3.76%235,843 | $25.72 | $237,113 | View SEC filing | |
| 2026-07-13 | Farquhar John C.M. Chief Executive Officer | Sale | -22,562 | -1.16%1,920,639 | $27.75 | $626,096 | View SEC filing | |
| 2026-06-26 | Farquhar John C.M. Chief Executive Officer | Sale | -38,900 | -1.96%1,943,201 | $35.00 | $1,361,500 | View SEC filing | |
| 2026-06-12 | Farquhar John C.M. Chief Executive Officer | Sale | -22,562 | -1.13%1,982,101 | $28.50 | $643,017 | View SEC filing | |
| 2026-05-20 | Rogers Campbell Chief Medical Officer | Sale | -9,219 | -3.63%245,062 | $28.34 | $261,266 | View SEC filing | |
| 2026-05-13 | Farquhar John C.M. Chief Executive Officer | Sale | -22,562 | -1.11%2,004,663 | $29.12 | $657,005 | View SEC filing | |
| 2026-04-30 | Bain Capital Life Sciences Investors, LLC 10% Owner | Sale | -2,000,000 | -19.14%8,448,158 | $29.45 | $58,898,336 | View SEC filing | |
| 2026-04-14 | Farquhar John C.M. Chief Executive Officer | Sale | -22,562 | -3.95%549,163 | $26.72 | $602,857 | View SEC filing | |
| 2026-04-03 | Rogers Campbell Chief Medical Officer | Sale | -64,533 | -22.17%226,542 | $24.64 | $1,590,093 | View SEC filing | |
| 2026-03-23 | Rogers Campbell Chief Medical Officer | Sale | -64,533 | -22.36%224,058 | $25.69 | $1,658,033 | View SEC filing | |
| 2026-03-20 | Farquhar John C.M. Chief Executive Officer | Sale | -9,725 | -1.67%571,725 | $25.00 | $243,125 | View SEC filing | |
| 2026-03-12 | Farquhar John C.M. Chief Executive Officer | Sale | -12,837 | -2.16%581,450 | $22.66 | $290,886 | View SEC filing | |
| 2026-03-06 | Cullivan Julie A Director | Sale | -9,122 | -25.05%27,291 | $25.00 | $228,050 | View SEC filing | |
| 2026-02-17 | Rogers Campbell Chief Medical Officer | Sale | -65,153 | -22.72%221,574 | $24.49 | $1,595,486 | View SEC filing | |
| 2026-02-10 | Farquhar John C.M. Chief Executive Officer | Sale | -22,562 | -3.67%591,656 | $27.46 | $619,553 | View SEC filing | |
| 2026-02-06 | Cullivan Julie A Director | Sale | -8,000 | -18.01%36,413 | $27.32 | $218,560 | View SEC filing | |
| 2026-02-06 | Bain Capital Life Sciences Investors, LLC 10% Owner | Sale | -2,000,000 | -16.07%10,448,158 | $28.05 | $56,100,000 | View SEC filing | |
| 2025-12-17 | Lightcap Jeffrey C Director | Purchase | +40,000 | +0.60%6,737,556 | $26.34 | $1,053,680 | View SEC filing |
1-18 of 18